TC
TwinBeech Capital Portfolio holdings
AUM
$4.41B
1-Year Return
2.18%
This Quarter Return
+3.07%
1 Year Return
+2.18%
3 Year Return
+6.49%
5 Year Return
-6.85%
10 Year Return
–
AUM
$4.94B
AUM Growth
-$326M
(-6.2%)
Cap. Flow
-$383M
Cap. Flow
% of AUM
-7.75%
Top 10 Holdings %
Top 10 Hldgs %
12.56%
Holding
966
New
308
Increased
126
Reduced
141
Closed
390
Top Buys
| 1 |
Sherwin-Williams
SHW
|
+$70.8M |
| 2 |
Cigna
CI
|
+$62.9M |
| 3 |
Broadcom
AVGO
|
+$62.5M |
| 4 |
PayPal
PYPL
|
+$61.6M |
| 5 |
Salesforce
CRM
|
+$61.5M |
Top Sells
| 1 |
Tractor Supply
TSCO
|
+$78.5M |
| 2 |
Colgate-Palmolive
CL
|
+$67.3M |
| 3 |
Palo Alto Networks
PANW
|
+$66.6M |
| 4 |
Boeing
BA
|
+$64.4M |
| 5 |
Arista Networks
ANET
|
+$57.8M |
Sector Composition
| 1 | Technology | 21% |
| 2 | Healthcare | 14.85% |
| 3 | Consumer Discretionary | 14.68% |
| 4 | Financials | 12.46% |
| 5 | Industrials | 11.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
XIFR
276
XPLR Infrastructure, LP
XIFR
$921M
| $3.9M | 0.08% |
+64,230
| New | +$3.9M |
|
|
AYX
277
DELISTED
Alteryx, Inc.
AYX
| $3.89M | 0.08% |
+66,102
| New | +$3.89M |
|
278
Amylyx Pharmaceuticals
AMLX
$1.03B
| $3.87M | 0.08% |
+131,772
| New | +$3.87M |
|
279
Dycom Industries
DY
$7.52B
| $3.85M | 0.08% |
+41,135
| New | +$3.85M |
|
280
Edwards Lifesciences
EW
$45.9B
| $3.85M | 0.08% |
46,554
-86,033
| -65% | -$7.12M |
|
281
Veeva Systems
VEEV
$45.1B
| $3.79M | 0.08% |
20,646
-255,565
| -93% | -$47M |
|
282
Bath & Body Works
BBWI
$5.76B
| $3.78M | 0.08% |
103,444
-192,437
| -65% | -$7.04M |
|
283
Varonis Systems
VRNS
$6.32B
| $3.77M | 0.08% |
+145,100
| New | +$3.77M |
|
284
Olin
OLN
$2.9B
| $3.75M | 0.08% |
+67,548
| New | +$3.75M |
|
285
Blue Owl Capital
OWL
$11.8B
| $3.72M | 0.08% |
+335,440
| New | +$3.72M |
|
286
Cullen/Frost Bankers
CFR
$8.18B
| $3.71M | 0.08% |
+35,263
| New | +$3.71M |
|
287
Zimmer Biomet
ZBH
$20.4B
| $3.7M | 0.08% |
+28,669
| New | +$3.7M |
|
288
Hormel Foods
HRL
$13.6B
| $3.7M | 0.07% |
92,796
+15,522
| +20% | +$619K |
|
289
ASGN Inc
ASGN
$2.25B
| $3.66M | 0.07% |
44,314
+35,903
| +427% | +$2.97M |
|
290
Toll Brothers
TOL
$13.7B
| $3.61M | 0.07% |
60,061
+47
| +0.1% | +$2.82K |
|
291
Zions Bancorporation
ZION
$8.46B
| $3.58M | 0.07% |
119,612
-89,693
| -43% | -$2.68M |
|
292
UiPath
PATH
$6.27B
| $3.56M | 0.07% |
+202,526
| New | +$3.56M |
|
293
Bilibili
BILI
$10.2B
| $3.55M | 0.07% |
150,910
+128,829
| +583% | +$3.03M |
|
294
monday.com
MNDY
$9.67B
| $3.54M | 0.07% |
+24,783
| New | +$3.54M |
|
295
Revolution Medicines
RVMD
$7.51B
| $3.51M | 0.07% |
+162,148
| New | +$3.51M |
|
296
National Vision
EYE
$1.78B
| $3.51M | 0.07% |
186,224
+31,501
| +20% | +$593K |
|
297
Goodyear
GT
$2.42B
| $3.45M | 0.07% |
313,407
-314,508
| -50% | -$3.47M |
|
298
UMB Financial
UMBF
$9.29B
| $3.45M | 0.07% |
+59,780
| New | +$3.45M |
|
299
Denali Therapeutics
DNLI
$2.17B
| $3.44M | 0.07% |
+149,302
| New | +$3.44M |
|
300
Griffon
GFF
$3.66B
| $3.4M | 0.07% |
+106,085
| New | +$3.4M |
|